What is the Sol-Gel Technologies Ltd. stock price forecast?

Sol-Gel Technologies Ltd. is currently trading at $72.87. View real-time AI analysis on Alpha Lenz.

What is Sol-Gel Technologies Ltd. insider trading activity?

View the latest insider trading data for Sol-Gel Technologies Ltd. on Alpha Lenz.

What is Sol-Gel Technologies Ltd.'s P/E ratio?

Sol-Gel Technologies Ltd.'s P/E ratio is -33.1.

Sol-Gel Technologies Ltd.

NASDAQ · SLGL

$72.87-0.95(-1.29%)Pre-market

Ask about Sol-Gel Technologies Ltd.'s future dividend policy...

Alpha Chat Insight

“Sol-Gel Technologies Ltd. trades at a P/E of -33.1 (undervalued) with modest ROE of -23.7%. 3Y revenue CAGR of 70.9% highlights clear growth momentum.”

Ask for details →

Company Overview

Sol-Gel Technologies Ltd. is a pharmaceutical company specializing in dermatological treatments utilizing its proprietary aerosol-based, drug-delivery platform. Founded in 1997 and headquartered in Israel, Sol-Gel develops topical dermatology products to address common skin conditions such as acne and rosacea. The company's innovative approach leverages nanotechnology to create microencapsulation systems that improve drug efficacy, stability, and patient experience. By focusing on these prevalent conditions, Sol-Gel plays a vital role in the pharmaceutical sector, particularly in advancing topical treatment technologies. With a commitment to research and development, Sol-Gel Technologies seeks collaborations and partnerships to further enhance its product pipeline and expand its market presence, contributing significantly to the dermatology therapeutics industry.

CEOMr. Moshe Arkin

Websitehttps://www.sol-gel.com

SectorHealthcare

IndustryBiotechnology

Employees34

Company Statistics

FY 2025

Profile

$203.01MMarket Cap

$19.39MRevenue

0.00Shares Out

34Employees

Margins

N/AGross

-38.32%EBITDA

-38.88%Operating

-31.60%Pre-Tax

-31.60%Net

Valuation

-33.13P/E

8.90P/B

10.47EV/Sales

-25.97EV/EBITDA

738.21P/FCF

Growth (CAGR)

70.92%Rev 3Yr

17.19%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-18.63%ROA

-23.72%ROE

-22.92%ROIC

Financial Health

$11.03MCash & Cash Equivalents

$-3.93MNet Debt

31.15%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Sol-Gel Technologies Ltd. trades at a P/E of -33.1 (undervalued) with modest ROE of -23.7%. 3Y revenue CAGR of 70.9% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

Sol-Gel Technologies Ltd. (ticker: SLGL) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 34 employees. Market cap is $203M.

The current price is $72.87 with a P/E ratio of -33.13x and P/B of 8.9x.

ROE is -23.72% and operating margin is -38.88%. Annual revenue is $19M.